Lisa Satter
Lisa Satter
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations | immune system disorder, inborn error of immunity | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-08 | NCT07670156 |